Marker | Data | Down syndrome; n (%) | No Down syndrome; n (%) |
Sex | Female | 2530 (49.1) | 672 072 (45.0) |
Male | 2620 (50.9) | 821 133 (55.0) | |
Missing data | 2 (0.0) | 180 (0.0) | |
Race | White | 2475 (48.5) | 665 971 (44.8) |
Black | 197 (3.9) | 63 920 (4.3) | |
Asian | 44 (0.9) | 14 349 (1.0) | |
Pardos (multiracial background) | 1690 (33.1) | 497 389 (33.5) | |
Indigenous | 12 (0.2) | 2438 (0.2) | |
Missing data | 682 (13.4) | 240 878 (16.2) | |
Age | Infancy period (<1 yo) | 151 (2.9) | 7219 (0.5) |
Childhood period (1–12 yo) | 221 (4.3) | 12 451 (0.8) | |
Youth period (13–24 yo) | 414 (8.0) | 25 892 (1.7) | |
Maturity period (25–60 yo) | 2919 (56.7) | 739 981 (49.6) | |
Presenile period (61–72 yo) | 779 (15.1) | 351 736 (23.6) | |
Senile period (73+ yo) | 668 (13.0) | 355 953 (23.6) | |
Place of residence | Urban | 4383 (85.1) | 1 257 973 (84.2) |
Rural | 296 (5.7) | 66 584 (4.5) | |
Peri-urban | 17 (0.3) | 4688 (0.3) | |
Missing data | 456 (8.9) | 164 131 (11.0) | |
Comorbidities | |||
Any | Yes | 5152 (100.0) | 1 001 312 (67.0) |
No | – | 492 073 (33.0) | |
Cardiopathy | Yes | 1847 (35.9) | 506 305 (33.9) |
No | 3260 (63.3) | 985 815 (66.0) | |
Missing data | 45 (0.9) | 1265 (0.1) | |
Haematological disorder | Yes | 394 (7.6) | 9687 (0.6) |
No | 4673 (90.7) | 1 481 471 (99.2) | |
Missing data | 85 (1.6) | 2227 (0.1) | |
Hepatic disorder | Yes | 403 (7.8) | 11 843 (0.8) |
No | 4672 (90.7) | 1 479 385 (99.1) | |
Missing data | 77 (1.5) | 2157 (0.1) | |
Diabetes mellitus | Yes | 1314 (25.5) | 365 400 (24.5) |
No | 3778 (73.3) | 1 126 638 (75.4) | |
Missing data | 60 (1.2) | 1288 (0.1) | |
Asthma | Yes | 416 (8.1) | 39 532 (2.6) |
No | 4663 (90.5) | 1 451 767 (97.2) | |
Missing data | 73 (1.4) | 2086 (0.1) | |
Neurological disorder | Yes | 546 (10.6) | 54 265 (3.6) |
No | 4528 (87.9) | 1 441 583 (96.2) | |
Missing data | 78 (1.5) | 2065 (0.1) | |
Chronic lung diseases | Yes | 429 (8.3) | 50 040 (3.4) |
No | 4649 (90.2) | 1 441 008 (96.5) | |
Missing data | 74 (1.4) | 2265 (0.2) | |
Immunosuppressive disorder | Yes | 346 (6.7) | 35 497 (2.4) |
No | 4731 (91.8) | 1 455 361 (97.5) | |
Missing data | 75 (1.5) | 2465 (0.2) | |
Kidney disorder | Yes | 349 (6.8) | 52 885 (3.5) |
No | 4728 (91.8) | 1 438 304 (96.3) | |
Missing data | 75 (1.5) | 2131 (0.1) | |
Obesity | Yes | 829 (16.1) | 140 053 (9.4) |
No | 4222 (81.9) | 1 345 504 (90.1) | |
Missing data | 101 (2.0) | 7760 (0.5) | |
Intensive care unit | Yes | 2225 (47.4) | 515 748 (39.0) |
No | 2471 (52.6) | 808 000 (61.0) | |
Mechanical ventilatory support | Invasive | 1382 (29.6) | 289 657 (22.2) |
Non-invasive | 2533 (54.3) | 778 689 (59.7) | |
None | 747 (16.0) | 237 062 (18.2) | |
Outcomes | Death | 2973 (57.7) | 963 967 (64.5) |
Clinical recovery | 2179 (42.3) | 529 418 (35.5) |
We presented the data as the number of individuals (n) and percentage (%). yo, years of age.
We retrieved the data from the Brazilian Ministry of Health platform (https://opendatasus.saude.gov.br/). The study comprised the period from 29 December 2019 to 20 March 2022.